Penumbra Inc PEN:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:45 AM EDT
191.08quote price arrow up+1.48 (+0.78%)
Volume
47,619
52 week range
114.86 - 290.36
Loading...
  • Open191.20
  • Day High194.77
  • Day Low187.87
  • Prev Close189.60
  • 52 Week High290.36
  • 52 Week High Date12/31/21
  • 52 Week Low114.86
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap7.24B
  • Shares Out37.89M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-33.24

KEY STATS

  • Open191.20
  • Day High194.77
  • Day Low187.87
  • Prev Close189.60
  • 52 Week High290.36
  • 52 Week High Date12/31/21
  • 52 Week Low114.86
  • 52 Week Low Date06/16/22
  • Market Cap7.24B
  • Shares Out37.89M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • YTD % Change-33.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-368.95
  • Fwd P/E (NTM)249.13
  • EBITDA (TTM)15.48M
  • ROE (TTM)-2.35%
  • Revenue (TTM)806.37M
  • Gross Margin (TTM)62.85%
  • Net Margin (TTM)-2.51%
  • Debt To Equity (MRQ)2.83%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Penumbra Inc

 

Profile

MORE
Penumbra, Inc. is a global healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that focuses on medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies....
Adam Elsesser J.D.
Chairman of the Board, President, Chief Executive Officer
Maggie Yuen
Chief Financial Officer
Lambert Shiu
Chief Accounting Officer
Johanna Roberts
Executive Vice President, General Counsel, Secretary
Address
One Penumbra Place
Alameda, CA
94502
United States

Top Peers

SYMBOLLASTCHG%CHG
GMED
Globus Medical Inc
60.35+0.78+1.31%
LNTH
Lantheus Holdings Inc
73.92+3.59+5.10%
MASI
Masimo Corp
142.91+1.75+1.24%
RGEN
Repligen Corp
195.31+8.20+4.38%
HAE
Haemonetics Corp
75.06+1.03+1.39%